The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms during this transition.

clinicalinfo.hiv.gov

Offering Information on HIV/AIDS Treatment, Prevention, and Research

Clinical Guidelines

Federally approved medical practice guidelines for HIV/AIDS.

Drug Database

Information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs.

Glossary

Medical dictionary of HIV-related terms.

Resources

HIV-related resources from the National Institutes of Health.

Overview

Read more about Overview

Table 5. Serious and/or Common Adverse Reactions Associated with Systemically Administered Drugs Used to Treat or Prevent Opportunistic Infections

Read more about Table 5. Serious and/or Common Adverse Reactions Associated with Systemically Administered Drugs Used to Treat or Prevent Opportunistic Infections

Table 4. Significant Pharmacokinetic Interactions Between Drugs Used to Treat or Prevent Opportunistic Infections

Read more about Table 4. Significant Pharmacokinetic Interactions Between Drugs Used to Treat or Prevent Opportunistic Infections

Table 3. Indications for Discontinuing and Restarting Primary and Secondary Prophylaxis (or Chronic Maintenance Therapy) for Selected Opportunistic Infections in Adults and Adolescents with HIV

Read more about Table 3. Indications for Discontinuing and Restarting Primary and Secondary Prophylaxis (or Chronic Maintenance Therapy) for Selected Opportunistic Infections in Adults and Adolescents with HIV

Table 2. Treatment of HIV-Associated Opportunistic Infections (Includes Recommendations for Acute Treatment and Secondary Prophylaxis/Chronic Suppressive/Maintenance Therapy)

Read more about Table 2. Treatment of HIV-Associated Opportunistic Infections (Includes Recommendations for Acute Treatment and Secondary Prophylaxis/Chronic Suppressive/Maintenance Therapy)

Table 1. Chemoprophylaxis to Prevent First Episode of Opportunistic Disease

Read more about Table 1. Chemoprophylaxis to Prevent First Episode of Opportunistic Disease

Appendix C. General Terms

Read more about Appendix C. General Terms

Appendix C: Drug Name Abbreviations

Read more about Appendix C: Drug Name Abbreviations

Cost Considerations and Antiretroviral Therapy

Read more about Cost Considerations and Antiretroviral Therapy

Adverse Effects of Antiretroviral Medications

Read more about Adverse Effects of Antiretroviral Medications